T Ohnuma
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Drug Transport and Resistance Mechanisms 3
- Biomaterials top 5%
- Dermatology top 5%
- Chemotherapy-related skin toxicity 4
- Pharmaceutical Science top 5%
- Reproductive Medicine top 10%
-
- Acute Lymphoblastic Leukemia research 5
-
- Cancer therapeutics and mechanisms 4
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Peter H. WiernikR. GrallaD L TrumpDavid A. Van EchoJames R. BakerRoss C. DonehowerR B WeissDaniel D. Von Hoff
- Cited by
- OncologyBiomaterialsDermatology
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (3 papers)Cancer (2 papers)
- Partner nations
- United StatesJapanFrance
In The Last Decade
T Ohnuma
40 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 812
- Biomaterials 354
- Dermatology 171
- Pharmaceutical Science 83
- Reproductive Medicine 73
Countries citing papers authored by T Ohnuma
This map shows the geographic impact of T Ohnuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Ohnuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Ohnuma more than expected).
Fields of papers citing papers by T Ohnuma
This network shows the impact of papers produced by T Ohnuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Ohnuma. The network helps show where T Ohnuma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T Ohnuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2011 | 4 | |
| 3 | 2006 | 11 | |
| 4 | Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer. | 1995 | 3 |
| 5 | 1994 | 41 | |
| 6 | Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. | 1994 | 87 |
| 7 | A somatostatin analogue (SMS 201-995) alters the toxicity of 5-fluorouracil in Swiss mice. | 1993 | 5 |
| 8 | 1991 | 2 | |
| 9 | Hypersensitivity reactions from taxol.breakdown → | 1990 | 951 |
| 10 | 1988 | 20 | |
| 11 | 1988 | 15 | |
| 12 | 1985 | 16 | |
| 13 | 1981 | 71 | |
| 14 | Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancer. | 1981 | 17 |
| 15 | 1980 | 35 | |
| 16 | 1980 | 2 | |
| 17 | 1980 | 8 | |
| 18 | cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer. | 1978 | 11 |
| 19 | Initial clinical study with pyrazofurin. | 1977 | 4 |
| 20 | Hepatic catalase activity in advanced human cancer. | 1966 | 22 |
About T Ohnuma
T Ohnuma is a scholar working on Oncology, Otorhinolaryngology, Dermatology, Pharmacology and Pharmaceutical Science, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Acute Lymphoblastic Leukemia research (5 papers), Cancer therapeutics and mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chemotherapy-related skin toxicity (4 papers), Lung Cancer Treatments and Mutations (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (812 citations), Biomaterials (354 citations), Dermatology (171 citations), Pharmaceutical Science (83 citations) and Reproductive Medicine (73 citations). T Ohnuma has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Peter H. Wiernik, R. Gralla, D L Trump, David A. Van Echo, James R. Baker, Ross C. Donehower, R B Weiss, Daniel D. Von Hoff, B Leyland-Jones and James F. Holland. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer, Recent results in cancer research and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.